Supportive Care


ASCO Calls for Improved Palliative Care (February 9, 2011)

The American Society of Clinical Oncology (ASCO) has released a new policy statement that calls for improvement of quality of life among patients with advanced disease (defined here as incurable disease).... Continue Reading

Social Support May Improve Breast Cancer Outcomes (January 26, 2011)

Social well-being during the first year after a breast cancer diagnosis may have a beneficial effect on cancer outcomes. These results were published in the Journal of Clinical Oncology. A diagnosis of... Continue Reading

Behavioral Therapy Reduces Incontinence after Prostatectomy (January 17, 2011)

Behavioral therapy with pelvic floor muscle exercises, bladder control techniques, and fluid management can reduce (but rarely eliminate) urinary incontinence after radical prostatectomy for early prostate... Continue Reading

Xgeva Delays Bone Complications in Women with Metastatic Breast Cancer (December 21, 2010)

In a study of women with bone metastases from breast cancer, Xgeva™ (denosumab) delayed bone complications for five months longer than Zometa® (zoledronic acid). These updated results from a Phase III... Continue Reading

Nplate Active for More than Five Years in Adults with Chronic ITP (December 13, 2010)

Nplate® (romiplostim) appears to maintain platelet counts among adult patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP) for more than five years. These results were presented at... Continue Reading

Weight and Exercise May Be Important Factors in Prostate Cancer (December 6, 2010)

Weight and exercise have once again demonstrated that they are each significant factors in the diagnosis, quality of life, and survival of prostate cancer. Results from several recent studies have concluded... Continue Reading

Moderate Aerobic Exercise May Help Combat Fatigue (December 4, 2010)

Study results indicate that moderate aerobic exercise may improve physical functioning in men who are receiving radiation therapy for localized prostate cancer and this improved physical functioning may... Continue Reading

Xgeva Approved for Patients with Bone Metastases (November 30, 2010)

Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related)... Continue Reading

Denosumab Delays Bone Complications in Women with Metastatic Breast Cancer (November 23, 2010)

Among women with bone metastases from breast cancer, denosumab may be more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. The results of this Phase... Continue Reading

Nplate Reduces Treatment Failure and Splenectomy in Patients with ITP (November 17, 2010)

Compared with standard therapies, Nplate® (romiplostim) appears to reduce the risk of treatment failure and need for splenectomy among adult patients with chronic immune thrombocytopenia (ITP). These... Continue Reading

« Previous PageNext Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS